Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3US
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,619
Award facts
- Contract value 100% obligated
- $12,618.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,618.71 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. The contract, awarded on January 26, 2026, with an ultimate completion date of January 27, 2026, represents a firm fixed-price procurement with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of medications and medical commodities to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical products. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the prime indefinite delivery contract with the DLA and competes on a full and open basis for federal contracts. The Zepbound supply supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the flexible IDC vehicle, demonstrating the contractor's capability to efficiently fulfill essential pharmaceutical requirements for military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FG3US?
SPE2DR26FG3US was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FG3US worth?
The government has obligated $12,619 on SPE2DR26FG3US.
Is contract SPE2DR26FG3US an order under another contract?
Yes. SPE2DR26FG3US is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3US competed?
The extent of competition for SPE2DR26FG3US was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award